Psychiatry · Vega Alta, PR
NPI
1700022282
Since 2009
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Km 31.7 Carr #2, Barrio Bajura
Vega Alta, PR, 00692
Phone (787) 941-3619
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$276K
15,304 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Katherine I Mercado-Nazario prescribed most often to Medicare patients was Clonazepam, with 2,262 prescriptions and refills. In total Katherine I Mercado-Nazario wrote 15,304 Medicare prescriptions that cost $276K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 2,262 | 2,270 | 282 | $31K |
| Sertraline Hcl Generic | 1,257 | 1,312 | 183 | $8,508 |
| Temazepam Generic | 1,084 | 1,084 | 140 | $9,143 |
| Lorazepam Generic | 933 | 933 | 151 | $8,564 |
| Trazodone Hcl Generic | 835 | 882 | 124 | $5,752 |
| Quetiapine Fumarate Generic | 767 | 813 | 93 | $6,549 |
| Escitalopram Oxalate Generic | 709 | 758 | 107 | $4,847 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 591 | 623 | 62 | $5,575 |
| Zolpidem Tartrate Generic | 519 | 519 | 71 | $4,256 |
| Fluoxetine Hcl Generic | 494 | 528 | 61 | $2,728 |
| Alprazolam Generic | 493 | 493 | 54 | $3,946 |
| Risperidone Generic | 491 | 507 | 60 | $3,147 |
| Duloxetine Hcl Generic | 491 | 551 | 70 | $6,111 |
| Bupropion Xl Bupropion Hcl | 462 | 506 | 62 | $11K |
| Buspirone Hcl Generic | 455 | 455 | 70 | $3,935 |
Brand drugs: 92 claims; generic drugs: 15,212 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Katherine I Mercado-Nazario were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.